Goldman Sachs Initiates Coverage On Abivax with Buy Rating, Announces Price Target of $155

Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $155.